The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Clinical trials suggesting that hemodiafiltration offers a survival benefit over hemodialysis have largely been conducted among the prevalent dialysis population, so investigators examined an incident ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

[5,6,7] Although the idea of a wearable artificial kidney (WAK) is not new, it is only the advent ... The outcomes of patients on chronic renal replacement therapy remain dismal with respect ...

Q1 2023 Earnings Call Transcript April 15, 2025 Spruce Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0 ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

As advancements in robotic-assisted knee replacement surgery continue to evolve, patients suffering from chronic knee pain ...

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...

Mitochondria play a crucial role in acquiring pluripotency and determining cell fate. The mitochondrial unfolded protein ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

As per Vantage Market Research, the Global Genomic Biomarkers Market has steadily grown due to the increasing demand for ...